EverSource Wealth Advisors’s INmune Bio INMB Stock Holding History

EverSource Wealth Advisors’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.86K	Buy	1,754 +816	+87%	+$1.13K	﹤0.01%	3565
2026 Q1	$1.06K	Buy	938 +857	+1,058%	+$1.22K	﹤0.01%	3841
2025 Q4	$126	Buy	+81	New	+$145	﹤0.01%	4079
2025 Q2	–	Sell	-9	Closed	-$70	–	4304
2025 Q1	$70	Buy	+9	New	+$71	﹤0.01%	3869

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

EverSource Wealth Advisors's INMB Position: Q2 2026 in Review

EverSource Wealth Advisors increased its INmune Bio (INMB) stake by 87% in Q2 2026, buying an estimated $1.13K and bringing the position to 1,754 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #3565.

EverSource Wealth Advisors first reported a position in INMB in Q1 2025 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

EverSource Wealth Advisors held 1,754 shares of INmune Bio worth $2.86K as of Q2 2026.
EverSource Wealth Advisors bought 816 INmune Bio shares in Q2 2026, an estimated $1.13K.
INmune Bio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3565 holding.
EverSource Wealth Advisors first reported a position in INmune Bio in Q1 2025 and has held it in 4 quarters since.
83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.